Associated Papers
Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review.
He L et al.
International Urology and Nephrology, 2025
Fibrinogen A Alpha-Chain Amyloidosis in Two Chinese Patients.
Li ZY et al.
Frontiers in Medicine, 2022
Fibrinogen A Alpha-Chain Amyloidosis Associated With a Novel Variant in a Chinese Family.
Jin S et al.
Kidney International Reports, 2021
Fibrinogen alpha amyloidosis: insights from proteomics.
Chapman J et al.
Expert Review of Proteomics, 2019
Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics.
Yazaki M et al.
International Journal of Molecular Sciences, 2018
VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants.
Garnier C et al.
Blood, 2017
Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis.
Gillmore JD et al.
Journal of the American Society of Nephrology : Jasn, 2009
Select a paper to view details